Vetio

What Vetio does

Vetio is a privately held veterinary pharmaceutical contract research and manufacturing organization (CRO/CDMO) founded in 2001 and headquartered in St Louis, United States. The company specializes in complex drug product formulation for animal health applications, serving veterinary pharmaceutical companies that require outsourced development, manufacturing, and regulatory support capabilities. Its positioning addresses a specialized niche within the broader pharmaceutical CDMO market—one focused on animal health products rather than human pharmaceuticals.

The company's service offering spans the full veterinary pharmaceutical product lifecycle, including preclinical and clinical research, formulation development, manufacturing, and regulatory support, based on the stated value proposition of being a partner for the manufacturing of veterinary pharmaceutical products. Vetio operates as a B2B services provider with a vertical segmentation approach, targeting veterinary pharmaceutical and biologics companies as its primary customer segment. The company maintains 101-250 employees, consistent with a mid-sized specialty CDMO.

The business model is project- and contract-based, typical of CDMO engagements, with revenue derived from formulation development fees, manufacturing contracts, and ongoing supply agreements. The company's go-to-market is relationship-driven within the animal health industry, leveraging two decades of accumulated formulation expertise. John Kane serves as Chief Executive Officer. The most recent disclosed capital event was a 2015 funding round from NorthStar Capital. The company has operated continuously for over 23 years, suggesting an established but not rapidly scaling market position within the veterinary pharmaceutical services sector.

Name

Vetio

Website

https://vetio.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

Vetio is a privately held veterinary pharmaceutical CRO/CDMO founded in 2001 in St Louis, United States, specializing in complex drug product formulation and contract manufacturing for animal health companies. It serves veterinary pharmaceutical and biologics firms with formulation, manufacturing, and regulatory support services.

Ownership category

akta.pro rank

Product category

Veterinary Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI)

akta.pro secondary industry

Compounding Pharmacies (Veterinary) (HLAMAIAD)

Keywords

• Contract manufacturing services
• Veterinary pharmaceuticals
• Drug formulation
• Animal health products
• Contract research services

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Core offering

Vetio specializes in complex drug product formulation and acts as a contract research and manufacturing partner for veterinary pharmaceutical products. The company delivers preclinical and clinical research, manufacturing, and regulatory support services for animal health products and biologics.

Product overview

No product information available. The source webpage (vetio.com) returned only a loading/verification page ("One moment, please...") without providing product, service, or company overview content.

Differentiator

Problem solved

Functional benefit

Products and services

• Veterinary Pharmaceutical Contract Manufacturing and Research Services End-to-end contract development, formulation, and manufacturing services for veterinary pharmaceuticals and biologics, including complex drug product formulation, preclinical/clinical research, and regulatory support, delivered to animal health companies.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Elanco Animal Health: Major animal health pharmaceutical company with internal manufacturing. Comparable as a leading buyer of veterinary CDMO services and as a benchmark for scale in the animal health value chain.
• CordenPharma: CDMOs providing API and drug product manufacturing across therapeutic areas including animal health. Comparable as a contract manufacturer with veterinary exposure and complex formulation expertise.
• Catalent: Major global CDMO with formulation, softgel, and biologic capabilities that also serve animal health customers. Comparable as a broad incumbent whose portfolio overlaps with Vetio's formulation focus.
• PCI Pharma Services: Large global CDMO providing drug development and manufacturing services including for animal health. Comparable as a much larger incumbent offering overlapping veterinary contract manufacturing.
• Eurofins CDMO: Contract development and manufacturing services within Eurofins' broader testing/life sciences platform, including support for animal health sponsors. Comparable as a CDMO serving veterinary pharmaceutical customers.
• Zoetis: World's largest animal health company, headquartered in the same St Louis cluster as Vetio. Comparable as both a potential CDMO customer and a benchmark for the veterinary pharma market Vetio serves.

Direct peers

• Huvepharma: Animal health and nutrition company with manufacturing and product development capabilities. Comparable as a mid-sized animal health player that both produces and sources CDMO capacity.
• Pillar5 Pharma: Specialty CDMO focused on sterile and non-sterile drug product manufacturing for animal health and human health clients. Comparable as a mid-sized CDMO serving veterinary pharma customers.
• Vetoquinol: Independent veterinary pharmaceutical company that both develops its own products and partners with manufacturers. Comparable as a customer-type and adjacent specialty animal health pharma peer.
• Kindeva Drug Delivery: Global CDMO with a dedicated animal health manufacturing franchise. Highly comparable as a contract manufacturer serving veterinary pharmaceutical sponsors with complex formulation and fill-finish capabilities.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vetio